<DOC>
	<DOC>NCT00703261</DOC>
	<brief_summary>The purpose of this study is to evaluate the utility of 18Fluorine Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET) as a tool to quantify atherosclerotic plaque.</brief_summary>
	<brief_title>Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Male or Female ages 30 to 80 Participant is on a low dose statin for at least 6 weeks prior to screening or is statinnaive at screening Participant has human immunodeficiency virus (HIV), Hepatitis B or C Participant uses illegal drugs Participant has Type I diabetes Participant has a history of claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>